Načítá se...
Single-Hormone Artificial Pancreas Use in Diabetes: Clinical Efficacy and Remaining Challenges
IN BRIEF Artificial pancreas systems are rapidly developing and constitute the most promising technology for insulin-requiring diabetes management. Single-hormone systems (SH-AP) that deliver only insulin and have a hybrid design that necessitates patients’ interventions around meals and exercise ar...
Uloženo v:
| Vydáno v: | Diabetes Spectr |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Diabetes Association
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6695251/ https://ncbi.nlm.nih.gov/pubmed/31462874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/ds18-0094 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|